About Microquin

Reenvisioning Hope at the Cellular Level

Founded in London (United Kingdom) in 2016, MicroQuin was born out of a collaborative and inclusive approach to research. MicroQuin is a biotechnology, R&D based company currently focusing on developing therapeutics to address a range of oncological disease. MicroQuin is progressing lead compounds into clinical trials, which offer a potential cure to Breast Cancer and other diseases.

Contact Microquin

More About Microquin

Therapeutic Areas
  • Autoimmune disorders
  • Oncology
  • Drug delivery
  • Peptides
  • Other
Company Type
  • Biotechnology – R&D services
State of Ownership
  • Private
Sponsorship Group
  • Networker